Steven R. Arikian

620 total citations
30 papers, 489 citations indexed

About

Steven R. Arikian is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Steven R. Arikian has authored 30 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Economics and Econometrics, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Epidemiology. Recurrent topics in Steven R. Arikian's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Nail Diseases and Treatments (4 papers). Steven R. Arikian is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers) and Nail Diseases and Treatments (4 papers). Steven R. Arikian collaborates with scholars based in United States, Canada and United Kingdom. Steven R. Arikian's co-authors include Thomas R. Einarson, Julian Casciano, John Doyle, Roman Casciano, Jack M. Gorman, Neil H. Shear, Jean‐Éric Tarride, Andy Surinach, G. Binder and Frank A. Corvino and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

Steven R. Arikian

30 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven R. Arikian United States 12 112 98 82 75 68 30 489
Raj Mehta United Kingdom 10 16 0.1× 63 0.6× 51 0.6× 16 0.2× 24 0.4× 16 630
Aurel O. Iuga United States 7 41 0.4× 17 0.2× 146 1.8× 23 0.3× 74 1.1× 8 800
Kathryn Anastassopoulos United States 11 34 0.3× 26 0.3× 8 0.1× 85 1.1× 19 0.3× 32 422
Irwin Brodsky United States 13 39 0.3× 52 0.5× 7 0.1× 281 3.7× 99 1.5× 25 919
Morton Allan Kapusta Canada 11 45 0.4× 122 1.2× 18 0.2× 27 0.4× 8 0.1× 16 397
Kelly Bell United States 15 96 0.9× 39 0.4× 46 0.6× 4 0.1× 52 0.8× 36 741
S. Cure United Kingdom 16 215 1.9× 31 0.3× 60 0.7× 3 0.0× 19 0.3× 39 565
Tianming Zhao China 14 52 0.5× 26 0.3× 6 0.1× 30 0.4× 35 0.5× 33 465
Merran Smith Australia 15 58 0.5× 42 0.4× 40 0.5× 11 0.1× 10 0.1× 20 756

Countries citing papers authored by Steven R. Arikian

Since Specialization
Citations

This map shows the geographic impact of Steven R. Arikian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven R. Arikian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven R. Arikian more than expected).

Fields of papers citing papers by Steven R. Arikian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven R. Arikian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven R. Arikian. The network helps show where Steven R. Arikian may publish in the future.

Co-authorship network of co-authors of Steven R. Arikian

This figure shows the co-authorship network connecting the top 25 collaborators of Steven R. Arikian. A scholar is included among the top collaborators of Steven R. Arikian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven R. Arikian. Steven R. Arikian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, B. Douglas, Amy E. DeZern, G. Binder, et al.. (2016). Patterns of total cost for patients (pts) with active treatment (Tx) of myelodysplastic syndromes (MDS).. Journal of Clinical Oncology. 34(15_suppl). e18252–e18252. 1 indexed citations
2.
McGuire, Alistair, et al.. (2002). A COST‐EFFECTIVENESS EVALUATION OF AMLODIPINE USAGE IN PATIENTS WITH CORONARY ARTERY DISEASE IN SWEDEN. International Journal of Clinical Practice. 56(2). 76–81. 5 indexed citations
3.
Flack, John M., Roman Casciano, Julian Casciano, et al.. (2002). Cardiovascular disease costs associated with uncontrolled hypertension.. PubMed. 15(11). 28–36. 43 indexed citations
4.
Thaulow, Erik, Roman Casciano, Julian Casciano, et al.. (2001). A pharmacoeconomic evaluation of amlodipine usage in patients undergoing PTCA in the US using results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES).. PubMed. 12(2). 31–5. 2 indexed citations
5.
Arikian, Steven R., et al.. (2001). PCV16: COST-EFFECTIVENESS OF AMLODIPINE TREATMENT IN PATIENTS WITH CORONARY ARTERY DISEASE IN THE U.K. Value in Health. 4(6). 494–494. 1 indexed citations
6.
7.
Arikian, Steven R. & Jack M. Gorman. (2001). A Review of the Diagnosis, Pharmacologic Treatment, and Economic Aspects of Anxiety Disorders. The Primary Care Companion For CNS Disorders. 3(3). 110–117. 33 indexed citations
8.
Arikian, Steven R., et al.. (2000). PHV14: A MULTINATIONAL PHARMACOECONOMIC EVALUATION OF THE SEVEN-VALENT PNEUMOCOCCAL CONJUGATE VACCINE. Value in Health. 3(2). 121–122. 3 indexed citations
9.
Einarson, Thomas R., Steven R. Arikian, Julian Casciano, & John Doyle. (1999). Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: A meta-analysis of randomized controlled trials. Clinical Therapeutics. 21(2). 296–308. 67 indexed citations
10.
Casciano, Julian, Steven R. Arikian, Jean‐Éric Tarride, John Doyle, & Roman Casciano. (1999). A pharmacoeconomic evaluation of major depressive disorder (Italy). Epidemiologia e Psichiatria Sociale. 8(3). 220–231. 6 indexed citations
11.
Shear, Neil H., Thomas R. Einarson, Steven R. Arikian, John Doyle, & D van Assche. (1998). Pharmacoeconomic analysis of topical treatments for tinea infections. International Journal of Dermatology. 37(1). 64–71. 9 indexed citations
12.
Murad, André M., et al.. (1997). Pharmacoeconomic Evaluation of Tegafur-Uracil (UFT) vs Fluorouracil for the Management of Colorectal Cancer in Brazil and Argentina. Clinical Drug Investigation. 13(2). 90–98. 9 indexed citations
13.
Doyle, John, Julian Casciano, Steven R. Arikian, Josephine Mauskopf, & John E. Paul. (1996). Full-Cost Determination of Different Levels of Care in the Intensive Care Unit. PharmacoEconomics. 10(4). 395–408. 10 indexed citations
14.
Arikian, Steven R., et al.. (1995). A multifactorial approach to understanding anesthesia selection. Health Care Management Review. 20(3). 7–15. 2 indexed citations
15.
Einarson, Thomas R., et al.. (1995). Rank-order Stability Analysis (ROSA). Medical Decision Making. 15(4). 367–372. 14 indexed citations
16.
Arikian, Steven R., et al.. (1995). Use of anesthesia selection in controlling surgery costs in an HMO hospital. Clinical Therapeutics. 17(3). 561–571. 18 indexed citations
17.
Shear, Neil H., Thomas R. Einarson, Steven R. Arikian, & John Doyle. (1995). Pharmacoeconomic Analysis of Topical Treatments for Tinea Infections. PharmacoEconomics. 7(3). 251–267. 6 indexed citations
18.
Arikian, Steven R., et al.. (1994). A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. British Journal of Dermatology. 130(s43). 35–44. 56 indexed citations
19.
Einarson, Thomas R., Steven R. Arikian, & Neil H. Shear. (1994). Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective. British Journal of Dermatology. 130(s43). 32–34. 39 indexed citations
20.
Panella, Marco Marzio, et al.. (1986). Dermoid cysts of the ovary.. PubMed. 7(3). 186–91. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raj Mehta Breakdown of academic impact, for papers by Aurel O. Iuga Breakdown of academic impact, for papers by Kathryn Anastassopoulos Breakdown of academic impact, for papers by Irwin Brodsky Breakdown of academic impact, for papers by Morton Allan Kapusta Breakdown of academic impact, for papers by Kelly Bell Breakdown of academic impact, for papers by S. Cure Breakdown of academic impact, for papers by Tianming Zhao Breakdown of academic impact, for papers by Merran Smith
Rankless by CCL
2026